Joseph Cobb has been named as the director of pharmaceutical development at the US contract development and manufacturing company Metrics.
The appointment is a promotion for Cobb, who has been with North Carolina-based Metrics since 2002, serving most recently as associate director of pharmaceutical development.
In his new role, Cobb will oversee Metrics’ work in early-phase solid oral dosage development, as well as the company’s potent and cytotoxic drug development services.
These services cover pharmaceutical formulation development; first-time- in-man formulations; and the manufacturing of clinical materials for trials covering phase I to III.
“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics’ formulation development capabilities,” said Phil Hodges, president of the company, which operates as a subsidiary of Mayne Pharma.
“With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”